{"transactions":[{"id":4624916,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-22T21:59:49.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":4008,"price":36.1459,"value":144872.7672,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":1157,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12024},"source":{"system":"sec-edgar","filing":"0002037144-26-000004","document":"form4-09222026_090944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000004/form4-09222026_090944.xml","form_type":"4"}},{"id":4624915,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-22T21:59:49.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":true,"shares":4008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":5165,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12024},"source":{"system":"sec-edgar","filing":"0002037144-26-000004","document":"form4-09222026_090944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000004/form4-09222026_090944.xml","form_type":"4"}},{"id":4624914,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:59:49.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":false,"shares":12024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II."}],"balance_after":258228,"source":{"system":"sec-edgar","filing":"0002037144-26-000004","document":"form4-09222026_090944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000004/form4-09222026_090944.xml","form_type":"4"}},{"id":4624913,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:59:49.000Z","date":"2026-09-18","kind":"tax_withholding","planned":true,"acquired":false,"shares":10626,"price":11.67,"value":124005.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects price per share in Ordinary Shares."}],"balance_after":270252,"source":{"system":"sec-edgar","filing":"0002037144-26-000004","document":"form4-09222026_090944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000004/form4-09222026_090944.xml","form_type":"4"}},{"id":1547,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":47.83,"value":4783.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1546,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":4539,"price":47.203,"value":214254.417,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $47.2030, and the range of prices were between $46.80 and $47.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":100,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4539},"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1545,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1300,"price":45.8642,"value":59623.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $45.8642 and the range of prices were between $45.63 and $46.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":4639,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1544,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":5939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"17,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 5,939 American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":5939,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5939},"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1543,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Share Option (right to buy)","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":17817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects price per share in Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Ordinary Shares vested one year after July 22, 2019 (the \"Vesting Commencement Date\"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 17,817 Ordinary Shares."}],"balance_after":125081,"derivative":{"exercise_price":0.34,"expiration_date":"2029-09-10","underlying":"Ordinary Shares","underlying_shares":17817},"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1542,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":17817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Ordinary Shares were converted into American Depositary Shares as reported in Table II."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":1541,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-03T01:18:28.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":17817,"price":0.34,"value":6057.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects price per share in Ordinary Shares."}],"balance_after":246777,"source":{"system":"sec-edgar","filing":"0001962926-26-000009","document":"form4-09032026_010924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1962926/000196292626000009/form4-09032026_010924.xml","form_type":"4"}},{"id":680756,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":400,"price":55.05,"value":22020.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The weighted average sale price for the transaction reported was $55.05 and the range of prices were between $54.85 and $55.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680755,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":519,"price":54.197,"value":28128.243,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $54.1970, and the range of prices were between $53.80 and $54.7950. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":400,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1557},"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680754,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":3020,"price":53.133,"value":160461.66,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $53.133 and the range of prices were between $52.77 and $53.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":919,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9060},"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680753,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":true,"shares":3939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":3939,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11817},"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680752,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Share Option (right to buy)","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":false,"shares":11817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects price per share in Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Ordinary Shares vested one year after July 22, 2019 (the \"Vesting Commencement Date\"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares."}],"balance_after":142898,"derivative":{"exercise_price":0.34,"expiration_date":"2029-09-10","underlying":"Ordinary Shares","underlying_shares":11817},"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680751,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":false,"shares":11817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Ordinary Shares were converted into American Depositary Shares as reported in Table II."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":680750,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-20T00:23:03.000Z","date":"2026-08-18","kind":"exercise","planned":true,"acquired":true,"shares":11817,"price":0.34,"value":4017.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects price per share in Ordinary Shares."}],"balance_after":240777,"source":{"system":"sec-edgar","filing":"0001962926-26-000008","document":"form4-08202026_120854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000008/form4-08202026_120854.xml","form_type":"4"}},{"id":692691,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":25309,"kind":"person","name":"Berrios John Joseph","position":1,"cik":"0002148420","reported_name":"Berrios John Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Share option (right to buy)","published_at":"2026-08-07T20:08:40.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":174612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares vest on the first anniversary of August 6, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":174612,"derivative":{"exercise_price":17.54,"expiration_date":"2036-08-05","underlying":"Ordinary Shares","underlying_shares":174612},"source":{"system":"sec-edgar","filing":"0002148420-26-000006","document":"form4-08072026_080836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000214842026000006/form4-08072026_080836.xml","form_type":"4"}},{"id":692690,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":25309,"kind":"person","name":"Berrios John Joseph","position":1,"cik":"0002148420","reported_name":"Berrios John Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-07T20:08:40.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":140766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted share units (\"RSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of August 6, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":140766,"source":{"system":"sec-edgar","filing":"0002148420-26-000006","document":"form4-08072026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000214842026000006/form4-08072026_080836.xml","form_type":"4"}},{"id":695037,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":839,"price":50.029,"value":41974.331,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $50.0290, and the range of prices were between $49.69 and $50.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2517},"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":695036,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":3100,"price":49.2857,"value":152785.67,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $49.2857 and the range of prices were between $48.66 and $49.65. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":839,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9300},"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":695035,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":3939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":3939,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11817},"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":695034,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Share Option (right to buy)","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":11817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects price per share in Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Ordinary Shares vested one year after July 22, 2019 (the \"Vesting Commencement Date\"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares."}],"balance_after":154715,"derivative":{"exercise_price":0.34,"expiration_date":"2029-09-10","underlying":"Ordinary Shares","underlying_shares":11817},"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":695033,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":11817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Ordinary Shares were converted into American Depositary Shares as reported in Table II."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":695032,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:49:34.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":11817,"price":0.34,"value":4017.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects price per share in Ordinary Shares."}],"balance_after":240777,"source":{"system":"sec-edgar","filing":"0001962926-26-000007","document":"form4-08052026_080829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000007/form4-08052026_080829.xml","form_type":"4"}},{"id":703720,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-07-24T13:11:48.000Z","date":"2026-07-22","kind":"sale","planned":false,"acquired":false,"shares":16085,"price":50.07,"value":805375.95,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.05 to $50.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":16086,"derivative":{"underlying":"Ordinary Shares","underlying_shares":48255},"source":{"system":"sec-edgar","filing":"0001193125-26-315240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526315240/ownership.xml","form_type":"4"}},{"id":703719,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-07-24T13:11:48.000Z","date":"2026-07-22","kind":"sale","planned":false,"acquired":false,"shares":1367,"price":50.07,"value":68445.69,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.05 to $50.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":1369,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4101},"source":{"system":"sec-edgar","filing":"0001193125-26-315240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526315240/ownership.xml","form_type":"4"}},{"id":708711,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":51.7088,"value":82734.08,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The weighted average sale price for the transaction reported was $51.7088, and the range of prices were between $51.32 and $52.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":708710,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"sale","planned":true,"acquired":false,"shares":6278,"price":50.7956,"value":318894.7768,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $50.7956 and the range of prices were between $50.31 and $51.30. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":1600,"derivative":{"underlying":"Ordinary Shares","underlying_shares":18834},"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":708709,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":7878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":7878,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23634},"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":708708,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Share Option (right to buy)","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":false,"shares":23634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects price per share in Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Ordinary Shares vested one year after July 22, 2019 (the \"Vesting Commencement Date\"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares."}],"balance_after":166532,"derivative":{"exercise_price":0.34,"expiration_date":"2029-09-10","underlying":"Ordinary Shares","underlying_shares":23634},"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":708707,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":false,"shares":23634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Ordinary Shares were converted into American Depositary Shares as reported in Table II."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":708706,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-07-15T22:57:56.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":23634,"price":0.34,"value":8035.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects price per share in Ordinary Shares."}],"balance_after":252594,"source":{"system":"sec-edgar","filing":"0001962926-26-000006","document":"form4-07152026_100751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000006/form4-07152026_100751.xml","form_type":"4"}},{"id":723599,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-06-30T00:32:35.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":7878,"price":49.0792,"value":386645.9376,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F7","text":"The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects price per share in American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23634},"source":{"system":"sec-edgar","filing":"0001962926-26-000005","document":"form4-06302026_120631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000005/form4-06302026_120631.xml","form_type":"4"}},{"id":723598,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-06-30T00:32:35.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":7878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F6","text":"23,634 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 7,878 American Depositary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date."}],"balance_after":7878,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23634},"source":{"system":"sec-edgar","filing":"0001962926-26-000005","document":"form4-06302026_120631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000005/form4-06302026_120631.xml","form_type":"4"}},{"id":723597,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Share Option (right to buy)","published_at":"2026-06-30T00:32:35.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":23634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects price per share in Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Ordinary Shares vested one year after July 22, 2019 (the \"Vesting Commencement Date\"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 23,634 Ordinary Shares."}],"balance_after":190166,"derivative":{"exercise_price":0.34,"expiration_date":"2029-09-10","underlying":"Ordinary Shares","underlying_shares":23634},"source":{"system":"sec-edgar","filing":"0001962926-26-000005","document":"form4-06302026_120631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000005/form4-06302026_120631.xml","form_type":"4"}},{"id":723596,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-06-30T00:32:35.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":23634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Ordinary Shares were converted into American Depositary Shares as reported in Table II."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000005","document":"form4-06302026_120631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000005/form4-06302026_120631.xml","form_type":"4"}},{"id":723595,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-06-30T00:32:35.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":23634,"price":0.34,"value":8035.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects price per share in Ordinary Shares."}],"balance_after":252594,"source":{"system":"sec-edgar","filing":"0001962926-26-000005","document":"form4-06302026_120631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000005/form4-06302026_120631.xml","form_type":"4"}},{"id":731717,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":33403,"kind":"person","name":"Russell Angus C.","position":1,"cik":"0001534002","reported_name":"Russell Angus C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:23.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001534002-26-000002","document":"form4-06182026_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534002/000153400226000002/form4-06182026_050614.xml","form_type":"4"}},{"id":731812,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":893,"kind":"person","name":"LOVE TED W","position":1,"cik":"0001188919","reported_name":"LOVE TED W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:21.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001188919-26-000010","document":"form4-06182026_050611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1188919/000118891926000010/form4-06182026_050611.xml","form_type":"4"}},{"id":731513,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36656,"kind":"person","name":"Waldstreicher Joanne","position":1,"cik":"0001962413","reported_name":"Waldstreicher Joanne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:16.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001962413-26-000002","document":"form4-06182026_050609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196241326000002/form4-06182026_050609.xml","form_type":"4"}},{"id":731799,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:11.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001202785-26-000004","document":"form4-06182026_050606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000120278526000004/form4-06182026_050606.xml","form_type":"4"}},{"id":731782,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36734,"kind":"person","name":"TETLOW SHARON","position":1,"cik":"0001328565","reported_name":"TETLOW SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:08.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001328565-26-000002","document":"form4-06182026_050604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1328565/000132856526000002/form4-06182026_050604.xml","form_type":"4"}},{"id":731818,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36750,"kind":"person","name":"WELCH DANIEL G","position":1,"cik":"0001206199","reported_name":"WELCH DANIEL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001206199-26-000002","document":"form4-06182026_050603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1206199/000120619926000002/form4-06182026_050603.xml","form_type":"4"}},{"id":801636,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":51455,"kind":"person","name":"Lang Matthew","position":1,"cik":"0001712069","reported_name":"Lang Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & GC"}}],"security":"Share option (right to buy)","published_at":"2026-04-23T20:21:05.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":223776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-fourth of the shares vest on the first anniversary of April 15, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":223776,"derivative":{"exercise_price":18.08,"expiration_date":"2036-04-14","underlying":"Ordinary Shares","underlying_shares":223776},"source":{"system":"sec-edgar","filing":"0001712069-26-000007","document":"form4-04232026_080401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712069/000171206926000007/form4-04232026_080401.xml","form_type":"4"}},{"id":801635,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":51455,"kind":"person","name":"Lang Matthew","position":1,"cik":"0001712069","reported_name":"Lang Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & GC"}}],"security":"Ordinary Shares","published_at":"2026-04-23T20:21:05.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":184614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of April 15, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":184614,"source":{"system":"sec-edgar","filing":"0001712069-26-000007","document":"form4-04232026_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712069/000171206926000007/form4-04232026_080401.xml","form_type":"4"}},{"id":807765,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-04-16T18:17:23.000Z","date":"2026-04-14","kind":"sale","planned":false,"acquired":false,"shares":16085,"price":55.07,"value":885800.95,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $55.00 to $55.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":32171,"derivative":{"underlying":"Ordinary Shares","underlying_shares":48255},"source":{"system":"sec-edgar","filing":"0001193125-26-158649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526158649/ownership.xml","form_type":"4"}},{"id":807764,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-04-16T18:17:23.000Z","date":"2026-04-14","kind":"sale","planned":false,"acquired":false,"shares":1367,"price":55.07,"value":75280.69,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $55.00 to $55.20. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":2736,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4101},"source":{"system":"sec-edgar","filing":"0001193125-26-158649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526158649/ownership.xml","form_type":"4"}},{"id":830478,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T20:30:11.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":40278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":40278,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":40278},"source":{"system":"sec-edgar","filing":"0001963664-26-000003","document":"form4-03232026_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000003/form4-03232026_040307.xml","form_type":"4"}},{"id":830477,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T20:30:11.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":32526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":139917,"source":{"system":"sec-edgar","filing":"0001963664-26-000003","document":"form4-03232026_040307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000003/form4-03232026_040307.xml","form_type":"4"}},{"id":830476,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T20:30:09.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":53703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":53703,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":53703},"source":{"system":"sec-edgar","filing":"0001962926-26-000003","document":"form4-03232026_040305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000003/form4-03232026_040305.xml","form_type":"4"}},{"id":830475,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T20:30:09.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":43368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":228960,"source":{"system":"sec-edgar","filing":"0001962926-26-000003","document":"form4-03232026_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000003/form4-03232026_040305.xml","form_type":"4"}},{"id":830474,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T20:30:08.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":128892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":128892,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":128892},"source":{"system":"sec-edgar","filing":"0001962414-26-000003","document":"form4-03232026_040303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196241426000003/form4-03232026_040303.xml","form_type":"4"}},{"id":830473,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T20:30:08.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":104085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":1401656,"source":{"system":"sec-edgar","filing":"0001962414-26-000003","document":"form4-03232026_040303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196241426000003/form4-03232026_040303.xml","form_type":"4"}},{"id":830813,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":14371,"kind":"person","name":"Stevens Raymond C","position":1,"cik":"0001698149","reported_name":"Stevens Raymond C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T20:30:06.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":322230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":322230,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":322230},"source":{"system":"sec-edgar","filing":"0001698149-26-000003","document":"form4-03232026_040301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698149/000169814926000003/form4-03232026_040301.xml","form_type":"4"}},{"id":830812,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":14371,"kind":"person","name":"Stevens Raymond C","position":1,"cik":"0001698149","reported_name":"Stevens Raymond C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T20:30:06.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":260217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":1401593,"source":{"system":"sec-edgar","filing":"0001698149-26-000003","document":"form4-03232026_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698149/000169814926000003/form4-03232026_040301.xml","form_type":"4"}},{"id":830846,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T16:30:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":59073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":59073,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":59073},"source":{"system":"sec-edgar","filing":"0001801842-26-000003","document":"form4-03232026_040310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000003/form4-03232026_040310.xml","form_type":"4"}},{"id":830845,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-23T16:30:16.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":47706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":155187,"source":{"system":"sec-edgar","filing":"0001801842-26-000003","document":"form4-03232026_040310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000003/form4-03232026_040310.xml","form_type":"4"}},{"id":831037,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-23T16:30:13.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":93984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":93984,"derivative":{"exercise_price":16.82,"expiration_date":"2036-03-18","underlying":"Ordinary Shares","underlying_shares":93984},"source":{"system":"sec-edgar","filing":"0002037144-26-000003","document":"form4-03232026_040308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000003/form4-03232026_040308.xml","form_type":"4"}},{"id":831036,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-23T16:30:13.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":75897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates."}],"balance_after":280878,"source":{"system":"sec-edgar","filing":"0002037144-26-000003","document":"form4-03232026_040308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000003/form4-03232026_040308.xml","form_type":"4"}},{"id":857650,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T23:20:13.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11313,"price":20.99,"value":237459.87,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":107391,"source":{"system":"sec-edgar","filing":"0001963664-26-000002","document":"form4-03052026_060310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196366426000002/form4-03052026_060310.xml","form_type":"4"}},{"id":857649,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T23:20:11.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":18735,"price":20.99,"value":393247.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":185592,"source":{"system":"sec-edgar","filing":"0001962926-26-000002","document":"form4-03052026_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196292626000002/form4-03052026_060307.xml","form_type":"4"}},{"id":857648,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T23:20:09.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":22305,"price":20.99,"value":468181.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":1297571,"source":{"system":"sec-edgar","filing":"0001962414-26-000002","document":"form4-03052026_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000196241426000002/form4-03052026_060306.xml","form_type":"4"}},{"id":858540,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":14371,"kind":"person","name":"Stevens Raymond C","position":1,"cik":"0001698149","reported_name":"Stevens Raymond C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"American Depositary Shares","published_at":"2026-03-05T23:20:05.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Voluntary reporting of the acquisition of 824 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":1824,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2472},"source":{"system":"sec-edgar","filing":"0001698149-26-000002","document":"form4-03052026_060301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698149/000169814926000002/form4-03052026_060301.xml","form_type":"4"}},{"id":858539,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":14371,"kind":"person","name":"Stevens Raymond C","position":1,"cik":"0001698149","reported_name":"Stevens Raymond C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T23:20:05.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":53454,"price":20.99,"value":1121999.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":1141376,"source":{"system":"sec-edgar","filing":"0001698149-26-000002","document":"form4-03052026_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698149/000169814926000002/form4-03052026_060301.xml","form_type":"4"}},{"id":859024,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-03-05T18:20:16.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11826,"price":20.99,"value":248227.74,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":204981,"source":{"system":"sec-edgar","filing":"0002037144-26-000002","document":"form4-03052026_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714426000002/form4-03052026_060312.xml","form_type":"4"}},{"id":858679,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"American Depositary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":462,"derivative":{"underlying":"Ordinary Shares","underlying_shares":711},"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":858678,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"American Depositary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":225,"derivative":{"underlying":"Ordinary Shares","underlying_shares":675},"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":858677,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T18:20:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4836,"price":20.99,"value":101507.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":107481,"source":{"system":"sec-edgar","filing":"0001801842-26-000002","document":"form4-03052026_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184226000002/form4-03052026_060304.xml","form_type":"4"}},{"id":936551,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":230,"price":85.04,"value":19559.2,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":48256,"derivative":{"underlying":"Ordinary Shares","underlying_shares":690},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936550,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":6498,"price":84.22,"value":547261.56,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":48486,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19494},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936549,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":3880,"price":83.35,"value":323398.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":54984,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11640},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936548,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":5477,"price":82.1,"value":449661.7,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":58864,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16431},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936547,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":20,"price":85.04,"value":1700.8,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":4103,"derivative":{"underlying":"Ordinary Shares","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936546,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":552,"price":84.22,"value":46489.44,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":4123,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1656},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936545,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":330,"price":83.35,"value":27505.5,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":4675,"derivative":{"underlying":"Ordinary Shares","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":936544,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2026-01-20T14:22:14.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":465,"price":82.1,"value":38176.5,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer."}],"balance_after":5005,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1395},"source":{"system":"sec-edgar","filing":"0001193125-26-016062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312526016062/ownership.xml","form_type":"4"}},{"id":975329,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":15535,"price":61.45,"value":954625.75,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $61.32 to $61.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":46605},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975328,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":16635,"price":61.05,"value":1015566.75,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $60.32 to $61.31. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":15535,"derivative":{"underlying":"Ordinary Shares","underlying_shares":49905},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975327,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":5589,"price":94.61,"value":528775.29,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $94.28 to $94.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":32170,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16767},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975326,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":2159,"price":94,"value":202946.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $93.27 to $94.26. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":37759,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6477},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975325,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":8337,"price":92.52,"value":771339.24,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $92.29 to $92.93. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":39918,"derivative":{"underlying":"Ordinary Shares","underlying_shares":25011},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975324,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":1320,"price":61.45,"value":81114.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $61.32 to $61.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":1,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3960},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975323,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":1414,"price":61.05,"value":86324.7,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $60.32 to $61.31. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":1321,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4242},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975322,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":475,"price":94.61,"value":44939.75,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $94.28 to $94.88. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":2735,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1425},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975321,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":183,"price":94,"value":17202.0,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $93.27 to $94.26. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":3210,"derivative":{"underlying":"Ordinary Shares","underlying_shares":549},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":975320,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-12-10T19:07:23.000Z","date":"2025-12-08","kind":"sale","planned":false,"acquired":false,"shares":709,"price":92.52,"value":65596.68,"ownership":{"direct":false,"nature":"F-Prime Capital Partners Life Sciences Advisors Fund VI LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $92.29 to $92.93. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":3393,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2127},"source":{"system":"sec-edgar","filing":"0001193125-25-313977","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/315066/000119312525313977/ownership.xml","form_type":"4"}},{"id":1034646,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56554,"kind":"person","name":"Hall Ashley","position":1,"cik":"0001801842","reported_name":"Hall Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-22T21:25:06.000Z","date":"2025-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":6021,"price":7.7433,"value":46622.4093,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":112317,"source":{"system":"sec-edgar","filing":"0001801842-25-000004","document":"form4-09222025_090903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801842/000180184225000004/form4-09222025_090903.xml","form_type":"4"}},{"id":1034894,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56604,"kind":"person","name":"Coll Crespo Blas","position":1,"cik":"0002037144","reported_name":"Coll Crespo Blas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-09-22T21:25:04.000Z","date":"2025-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":8106,"price":7.7433,"value":62767.1898,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":216807,"source":{"system":"sec-edgar","filing":"0002037144-25-000003","document":"form4-09222025_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037144/000203714425000003/form4-09222025_090901.xml","form_type":"4"}},{"id":1059803,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-08-20T21:00:16.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4470,"price":6.8366,"value":30559.602,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":118704,"source":{"system":"sec-edgar","filing":"0001415889-25-022472","document":"form4-08202025_050803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925022472/form4-08202025_050803.xml","form_type":"4"}},{"id":1059802,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-08-20T21:00:11.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":12846,"price":6.8366,"value":87822.9636,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":204327,"source":{"system":"sec-edgar","filing":"0001415889-25-022471","document":"form4-08202025_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925022471/form4-08202025_050801.xml","form_type":"4"}},{"id":1077965,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":28868,"kind":"organization","name":"FMR LLC","position":1,"cik":"0000315066","reported_name":"FMR LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remark 1"}}],"security":"American Depositary Shares","published_at":"2025-08-01T13:34:05.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":26310,"price":17.87,"value":470159.7,"ownership":{"direct":false,"nature":"Shares held by persons and entities whose shares are subject to reporting by the undersigned"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice."}],"balance_after":1515558,"derivative":{"underlying":"Ordinary Shares","underlying_shares":78930},"source":{"system":"sec-edgar","filing":"0000950170-25-101141","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/315066/000095017025101141/ownership.xml","form_type":"4"}},{"id":1091688,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:11.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":24459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 15, 2024, the reporting person was granted performance-vesting restricted share units (\"PSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date."}],"balance_after":123174,"source":{"system":"sec-edgar","filing":"0001415889-25-019353","document":"form4-07032025_050708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019353/form4-07032025_050708.xml","form_type":"4"}},{"id":1091687,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56467,"kind":"person","name":"Ma Yingli","position":1,"cik":"0001963664","reported_name":"Ma Yingli","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNOLOGY OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:11.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1824,"price":7.9166,"value":14439.8784,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":98715,"source":{"system":"sec-edgar","filing":"0001415889-25-019353","document":"form4-07032025_050708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019353/form4-07032025_050708.xml","form_type":"4"}},{"id":1091686,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:09.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":57078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 15, 2024, the reporting person was granted performance-vesting restricted share units (\"PSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date."}],"balance_after":217173,"source":{"system":"sec-edgar","filing":"0001415889-25-019352","document":"form4-07032025_050706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019352/form4-07032025_050706.xml","form_type":"4"}},{"id":1091685,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":1223,"kind":"person","name":"Lin Xichen","position":1,"cik":"0001962926","reported_name":"Lin Xichen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:09.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6441,"price":7.9166,"value":50990.8206,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":160095,"source":{"system":"sec-edgar","filing":"0001415889-25-019352","document":"form4-07032025_050706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019352/form4-07032025_050706.xml","form_type":"4"}},{"id":1091684,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"American Depositary Shares","published_at":"2025-07-03T21:15:08.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":2946,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2963},"source":{"system":"sec-edgar","filing":"0001415889-25-019351","document":"form4-07032025_050704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019351/form4-07032025_050704.xml","form_type":"4"}},{"id":1091683,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:08.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7089,"price":6.8366,"value":48464.6574,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award."}],"balance_after":1319876,"source":{"system":"sec-edgar","filing":"0001415889-25-019351","document":"form4-07032025_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019351/form4-07032025_050704.xml","form_type":"4"}},{"id":1091682,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":56466,"kind":"person","name":"Yoon Jun","position":1,"cik":"0001962414","reported_name":"Yoon Jun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-07-03T21:15:08.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":39606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents three Ordinary Shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 15, 2024, the reporting person was granted performance-vesting restricted share units (\"PSUs\"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date."}],"balance_after":1326965,"source":{"system":"sec-edgar","filing":"0001415889-25-019351","document":"form4-07032025_050704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1888886/000141588925019351/form4-07032025_050704.xml","form_type":"4"}}],"next_cursor":"2025-07-03T21:15:08.000000Z,1091682"}